AAAAAA
Results:
1-13
|
Results: 13
Authors:
Golab, J
Zagozdzon, R
Kaminski, R
Kozar, K
Gryska, K
Izycki, D
Mackiewicz, A
Stoklosa, T
Giermasz, A
Lasek, W
Jakobisiak, M
Citation: J. Golab et al., Potentiated antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo, LEUKEMIA, 15(4), 2001, pp. 613-620
Authors:
Giermasz, A
Nowis, D
Jalili, A
Basak, G
Marczak, M
Makowski, M
Czajka, A
Mlynarczuk, I
Hoser, G
Stok, T
Lewandowski, S
Jakobisiak, M
Citation: A. Giermasz et al., Antitumor activity of tributyrin in murine melanoma model, CANCER LETT, 164(2), 2001, pp. 143-148
Authors:
Wojcik, C
Bury, M
Stoklosa, T
Giermasz, A
Feleszko, W
Mlynarczuk, I
Pleban, E
Basak, G
Omura, S
Jakobisiak, M
Citation: C. Wojcik et al., Lovastatin and simvastatin are modulators of the proteasome, INT J BIO C, 32(9), 2000, pp. 957-965
Authors:
Feleszko, W
Mlynarczuk, I
Balkowiec-Iskra, EZ
Czajka, A
Switaj, T
Stoklosa, T
Giermasz, A
Jakobisiak, M
Citation: W. Feleszko et al., Lovastatin potentiates antitumor activity and attenuates cardiotoxicity ofdoxorubicin in three tumor models in mice, CLIN CANC R, 6(5), 2000, pp. 2044-2052
Authors:
Golab, J
Zagozdzon, R
Kozar, K
Kaminski, R
Giermasz, A
Stoklosa, T
Lasek, W
Jakobisiak, M
Citation: J. Golab et al., Potentiatied anti-tumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivo, ONCOL REP, 7(1), 2000, pp. 177-181
Authors:
Dabrowska, A
Giermasz, A
Marczak, M
Golab, J
Jakobisiak, M
Citation: A. Dabrowska et al., Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice, ANTICANC R, 20(1A), 2000, pp. 391-394
Authors:
Golab, J
Kozar, K
Kaminski, R
Czajka, A
Marczak, M
Switaj, T
Giermasz, A
Stoklosa, T
Lasek, W
Zagozdzon, R
Mucha, K
Jakobisiak, M
Citation: J. Golab et al., Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice, LIFE SCI, 66(13), 2000, pp. 1223-1230
Authors:
Golab, J
Wilczynski, G
Zagozdzon, R
Stoklosa, T
Dabrowska, A
Rybczynska, J
Wasik, M
Machaj, E
Oldak, T
Kozar, K
Kaminski, R
Giermasz, A
Czajka, A
Lasek, W
Feleszko, W
Jakobisiak, M
Citation: J. Golab et al., Potentiation of the anti-tumour effects of Photofrin (R)-based photodynamic therapy by localized treatment with G-CSF, BR J CANC, 82(8), 2000, pp. 1485-1491
Authors:
Dabrowska, A
Golab, J
Giermasz, A
Marczak, M
Jakobisiak, M
Citation: A. Dabrowska et al., Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents, J NAT CANC, 91(9), 1999, pp. 804-805
Authors:
Lasek, W
Golab, J
Maslinski, W
Switaj, T
Balkowiec, EZ
Stoklosa, T
Giermasz, A
Malejczyk, M
Jakobisiak, M
Citation: W. Lasek et al., Subtherapeutic doses of interleukin-15 augment the anti-tumor effect of interleukin-12 in a B16F10 melanoma model in mice, EUR CYTOKIN, 10(3), 1999, pp. 345-356
Authors:
Zagozdzon, R
Giermasz, A
Golab, J
Stoklosa, T
Jalili, A
Jakobisiak, M
Citation: R. Zagozdzon et al., The potentiated antileukemic effects of doxorubicin and interleukin-12 combination are not dependent on nitric oxide production, CANCER LETT, 147(1-2), 1999, pp. 67-75
Authors:
Feleszko, W
Balkowiec, EZ
Sieberth, E
Marczak, M
Dabrowska, A
Giermasz, A
Czajka, A
Jakobisiak, M
Citation: W. Feleszko et al., Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis, INT J CANC, 81(4), 1999, pp. 560-567
Authors:
Stoklosa, T
Wojcik, C
Golab, J
Giermasz, A
Wilk, S
Citation: T. Stoklosa et al., Inhibition of proteasome, apoptosis and sensitization to tumour necrosis factor alpha: do they always go together?, BR J CANC, 79(2), 1999, pp. 375-376
Risultati:
1-13
|